First-in-human study of TG-1801, a CD19/CD47 bispecific antibody ± ublituximab in BCL VJHemOnc – Video Journal of Hematology & HemOnc 1:22 1 year ago 191 Далее Скачать
Results from the first-in-human trial of TG-1801 in patients with B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 3:48 1 year ago 259 Далее Скачать
Acalabrutinib in combination with umbralisib and ublituximab in previously untreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:27 1 year ago 120 Далее Скачать
Ublituximab (Briumvi) - Drug Rx Information Health Information For All 4:06 1 year ago 155 Далее Скачать
Umbralisib and ublituximab in patients with CLL and comorbidities VJHemOnc – Video Journal of Hematology & HemOnc 1:55 2 years ago 104 Далее Скачать
HST-1011, an oral CBL-B inhibitor, alone and in combination with anti-PD1 in advanced solid tumors VJOncology 0:40 1 year ago 196 Далее Скачать
BGB-11417-101: first-in-human trial of BGB-1147 for R/R B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 3:04 3 years ago 352 Далее Скачать
First-in-human trial of intratumoral injection of SYNB1891 VJOncology 8:12 3 years ago 141 Далее Скачать
Dr. Scott Gettinger on the PD-1 Inhibitor BMS-936558 in Non-Small Cell Lung Cancer OncLive 1:23 12 years ago 1 292 Далее Скачать
Real-time distribution and uptake of bisphophonate in 4T1 breast tumour Garvan Institute of Medical Research 0:12 10 years ago 6 941 Далее Скачать
One Health Approach to Controlling Escherichia albertii, the Emerging Human Pathogen UT One Health Initiative 2:45 3 years ago 68 Далее Скачать
